Shree Cement, Coromandel International, Dr Lal PathLabs share prices will remain in focus as will traded trade ex-date today.

Bridgewater Associates' flagship fund Pure Alpha posted a gain of 8.2% in January, in a period when investors navigated a ...

Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...

Stocks on Wall Street surrendered early gains and closed broadly lower Friday after the White House said President Donald ...

Healthcare stocks have jumped, but the easy money has already been made. The ETF, home to health insurers, drugmakers, and ...

Fidelity has offered ETFs since 2003 and now has dozens of them in a wide range of sectors and industries. You can find ...

On Monday, Kay & Que (Bangladesh), a publicly listed company, was also downgraded to the Z category for the same reason.

Regeneron beat Q4 estimates with $12.07 EPS and $3.79B in sales. The company announced a dividend, a $3 billion buyback, and continued R&D investments.

Aspiring retirees spend many years saving up money so they have a large enough nest egg for retirement. It’s common for young ...

With a cost of $0 for this AI tech, the reasoning goes, there’s no reason to spend billions on AI from companies like OpenAI ...

DUBLIN, Ga., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Morris State Bancshares, Inc. (OTCQX: MBLU) (the “Company”), the parent of Morris Bank (the “Bank”), today reported its financial results for the quarter ...

(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...